Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients

BACKGROUND AND AIM: Hepatitis C virus (HCV) therapy should be considered without delay in all patients with significant (SIGFIB) or advanced liver fibrosis (ADVFIB). We aimed to investigate the rates of treatment initiation with interferon-free regimens within a screening program for SIGFIB/ADVFIB i...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Wien Klin Wochenschr
Glavni autori: Chromy, David, Schwabl, Philipp, Bucsics, Theresa, Scheiner, Bernhard, Strassl, Robert, Mayer, Florian, Aichelburg, Maximilian C., Grabmeier-Pfistershammer, Katharina, Trauner, Michael, Peck-Radosavljevic, Markus, Reiberger, Thomas, Mandorfer, Mattias
Format: Artigo
Jezik:Inglês
Izdano: Springer Vienna 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5816107/
https://ncbi.nlm.nih.gov/pubmed/28744597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00508-017-1231-x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items